
State Board of Administration of Florida Retirement System’s Inovio Pharmaceuticals INO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-95,027
| Closed | -$77.9K | – | 2458 |
|
2023
Q1 | $77.9K | Hold |
95,027
| – | – | ﹤0.01% | 2185 |
|
2022
Q4 | $148K | Hold |
95,027
| – | – | ﹤0.01% | 2127 |
|
2022
Q3 | $164K | Hold |
95,027
| – | – | ﹤0.01% | 2115 |
|
2022
Q2 | $164K | Buy |
95,027
+10
| +0% | +$17 | ﹤0.01% | 2165 |
|
2022
Q1 | $341K | Hold |
95,017
| – | – | ﹤0.01% | 1957 |
|
2021
Q4 | $474K | Sell |
95,017
-847
| -0.9% | -$4.23K | ﹤0.01% | 1848 |
|
2021
Q3 | $686K | Hold |
95,864
| – | – | ﹤0.01% | 1647 |
|
2021
Q2 | $889K | Buy |
95,864
+33,421
| +54% | +$310K | ﹤0.01% | 1546 |
|
2021
Q1 | $579K | Sell |
62,443
-2,940
| -4% | -$27.3K | ﹤0.01% | 1723 |
|
2020
Q4 | $579K | Hold |
65,383
| – | – | ﹤0.01% | 1700 |
|
2020
Q3 | $758K | Buy |
65,383
+2,440
| +4% | +$28.3K | ﹤0.01% | 1448 |
|
2020
Q2 | $1.7M | Buy |
62,943
+30,353
| +93% | +$818K | ﹤0.01% | 1063 |
|
2020
Q1 | $242K | Buy |
32,590
+5,860
| +22% | +$43.5K | ﹤0.01% | 1828 |
|
2019
Q4 | $88K | Hold |
26,730
| – | – | ﹤0.01% | 2217 |
|
2019
Q3 | $55K | Hold |
26,730
| – | – | ﹤0.01% | 2244 |
|
2019
Q2 | $79K | Hold |
26,730
| – | – | ﹤0.01% | 2269 |
|
2019
Q1 | $100K | Hold |
26,730
| – | – | ﹤0.01% | 2260 |
|
2018
Q4 | $107K | Hold |
26,730
| – | – | ﹤0.01% | 2247 |
|
2018
Q3 | $149K | Hold |
26,730
| – | – | ﹤0.01% | 2302 |
|
2018
Q2 | $105K | Hold |
26,730
| – | – | ﹤0.01% | 2352 |
|
2018
Q1 | $126K | Hold |
26,730
| – | – | ﹤0.01% | 2320 |
|
2017
Q4 | $110K | Hold |
26,730
| – | – | ﹤0.01% | 2347 |
|
2017
Q3 | $169K | Hold |
26,730
| – | – | ﹤0.01% | 2314 |
|
2017
Q2 | $210K | Hold |
26,730
| – | – | ﹤0.01% | 2262 |
|
2017
Q1 | $177K | Hold |
26,730
| – | – | ﹤0.01% | 2239 |
|
2016
Q4 | $186K | Hold |
26,730
| – | – | ﹤0.01% | 2252 |
|
2016
Q3 | $249K | Hold |
26,730
| – | – | ﹤0.01% | 2154 |
|
2016
Q2 | $247K | Buy |
26,730
+2,768
| +12% | +$25.6K | ﹤0.01% | 2124 |
|
2016
Q1 | $209K | Buy |
+23,962
| New | +$209K | ﹤0.01% | 2197 |
|